The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: 0.50 (1.64%)
Spread: 2.00 (6.667%)
Open: 31.00
High: 31.00
Low: 31.00
Prev. Close: 30.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement: Trading update

17 Mar 2017 18:25

RNS Number : 8736Z
Ilika plc
17 March 2017
 

A number of non material typographical changes have been made to the 'Trading update' announcement released on 17 March 2017 at 07.00 under RNS No 7455Z.

 

The changes are identified with an asterisk (*).

 

The full amended text is shown below.

 

17 March 2017

Ilika plc

("Ilika" or the "Company")

 

Trading update

 

Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces the following update on trading.

 

Revenue update

Since its last trading update in November 2016, the Company has announced four significant commercial deals, which are resulting in a strong ramp-up of revenue relative to 2015/16 and which will continue to support revenue growth into 2017/18. We expect to start 2017/18 with a record level of revenue commitments amounting to around £1.8m.

 

Ilika's stated business aim is to add licensing revenue to the development revenue it currently generates. While levels of interest are encouraging, predicting the timing of when these licenses will generate revenue remains a significant forecasting challenge for the Company. Given our proximity to the end of Ilika's current financial year and the duration of negotiations with OEM potential licensees, it seems increasingly likely that revenue from licensing may first have an impact in 2017/18.

 

Stereax roadmap update

Ilika has continued to develop its Stereax intellectual property in accordance with its roadmap, which it updates in line with feedback from its pipeline of development partners. Earlier this month, Ilika confirmed that it had secured a partnership with a bioelectronics company*, focused on optimising the Stereax platform for use in miniature medical implants*. Bioelectronics is a rapidly developing market with large opportunities that match the unique benefits that Stereax offers. Stereax's high volumetric energy density, manufacturability at mm-scale and the ability to deliver pulses of power are ideal for such devices. *

 

Towards the end of last year, Ilika announced the start of a funded collaborative project with Sharp Laboratories of Europe ("Sharp") to create a device consisting of an integrated StereaxTM solid-state battery and a photovoltaic panel, offering an autonomous energy harvesting device for wireless components. The initial concept was designed to address opportunities in automotive and wearables, but publicity around the project has also attracted interest from consumer goods companies looking for innovative ways to promote their products in retail outlets.

 

The next product milestone on Ilika's Stereax roadmap is its industrial battery, code-named Endeavour, which will be able to operate in an extended temperature range covering -40 to 150 degree Celsius. This battery is designed to meet the requirements of Industrial IoT, sometimes called Industry 4.0. A discussion of applications is covered in our recently-posted video featuring Meggitt and IBM which can be found here - http://www.ilika.com/news/videos.

 

Materials development programmes

While the Company is deploying most of its operational and commercial resources on Stereax activities, it has also seen an increase in materials development programmes on its high throughput technology platform. Last month Ilika announced that it had received notification of a renewal of the commercial relationship it has with Seagate to develop photonic materials and processes for Hard Disk Drive ("HDD") technology.

 

Ilika has also recently announced the renewal and strengthening of its long-standing relationship with Toyota. This has been triggered by the award of a contract by the Toyota Research Institute in the USA, which was founded at the end of 2015 with an initial focus on artificial intelligence, robotics and materials innovation.

 

The Company will announce a more detailed update on the outturn for 2016/17 in May prior to issuing its full year results in July.

 

Graeme Purdy, CEO of Ilika, commented: "We are continuing to see a reinforcement of our customer relationships, with long-standing partnerships with companies like Toyota and Seagate being further cemented. It's also great to see the upturn in revenues relative to last year allowing us to start 2017/18 with such a strong order book. The number of potential licensees, their level of interest and the diversity of applications is giving us growing confidence in our licensing model."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan/ Paul Gillam (Corporate Adviser)

 

James Black/ Michael Burke (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDXCBBBGRR
Date   Source Headline
29th Sep 20163:10 pmRNSResult of AGM
27th Sep 20167:00 amRNSPlacing
19th Sep 20167:00 amRNSVapour Deposition Method European Patent Grant
31st Aug 20167:00 amRNSPosting of Annual Report & Notice of AGM
16th Aug 20167:00 amRNSGrant Award
8th Jul 20167:00 amRNSFinal Results
5th Jul 20167:00 amRNSGrant of Battery Patent in China
24th Jun 20167:00 amRNSNotice of Results
27th Apr 20167:00 amRNSIlika transforms battery technology for IoT
25th Apr 20165:56 pmRNSExercise of Options and Total Voting Rights
11th Apr 20162:06 pmRNSAnalyst and Investor presentation
15th Mar 20167:00 amRNSLaunch of battery technology at IDTechEx
25th Feb 20167:00 amRNSGrant Award
16th Feb 20168:33 amRNSExercise of Options and Total Voting Rights
12th Jan 20167:00 amRNSHalf Yearly Report
4th Dec 20157:00 amRNSTrading Update
30th Nov 20156:07 pmRNSHolding(s) in Company
3rd Nov 20151:53 pmRNSDirector/PDMR Shareholding
21st Oct 20151:00 pmRNSDirector/PDMR Shareholding
12th Oct 20154:08 pmRNSExercise of Options and Total Voting Rights
1st Oct 20153:38 pmRNSGrant of Options
30th Sep 20153:14 pmRNSResult of AGM
30th Sep 20157:00 amRNSAGM Statement
29th Sep 20157:00 amRNSPatent Grant for solid-state batteries in China
22nd Sep 20157:00 amRNSGrant awarded to research self-healing alloys
4th Sep 20157:00 amRNSPosting of Annual Report & Notice of AGM
13th Aug 20157:00 amRNSUpdate on fuel cell catalyst patent in Europe
10th Jul 20157:01 amRNSDirectorate Change
10th Jul 20157:00 amRNSFinal Results
16th Jun 20157:00 amRNSNotice of Results
22nd Apr 20157:00 amRNSInvestor teach-in
16th Apr 20153:59 pmRNSHolding(s) in Company
16th Apr 20151:51 pmRNSHolding(s) in Company
16th Apr 20151:33 pmRNSHolding(s) in Company
10th Apr 201512:29 pmRNSHolding(s) in Company
26th Mar 20157:00 amRNSStart of solid-state battery pilot production
25th Mar 20159:31 amRNSHolding(s) in Company
23rd Mar 201510:36 amRNSHolding(s) in Company
17th Mar 20157:00 amRNSUpdate on patents for solid-state batteries
5th Mar 201511:03 amRNSHolding(s) in Company
4th Mar 20155:59 pmRNSDirectors Dealings, Exercise of Options & TVR
27th Feb 20157:00 amRNSGrant of Share Options
22nd Jan 20157:00 amRNSHalf Yearly Report
21st Jan 20152:48 pmRNSConversion of Securities
5th Jan 201511:43 amRNSHolding(s) in Company
22nd Dec 201411:16 amRNSConversion of Securities
21st Nov 20147:00 amRNSOpening of the pilot line & trading update
28th Oct 20147:00 amRNSDirectorate Changes
26th Sep 20144:07 pmRNSHolding(s) in Company
26th Sep 20143:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.